Back to results
US 5,691,379 AGranted
Dihydrolipoic acid as an ophthalmological agent to suppress intolerance reactions in the area between implants and living body tissue
AssigneeAsta Medica Aktiengesellschaft
InventorsHeinz Ulrich, Erich Franz Elstner
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions comprising dihydrolipoic acid or physiologically acceptable salts thereof are disclosed for the treatment of eye diseases and intolerance reactions in the area between implants and endoprostheses, in particular ophthalmological implants and endoprostheses with living body tissue.
Claims8
A method of suppressing or reducing an intolerance reaction resulting from an implant or endoprosthesis comprising
- contacting an area of living tissue in contact with or near the implant or endoprosthesis with an effective amount of a pharmaceutical composition comprising dihydrolipoic acid, or a physiologically acceptable salt of dihydrolipoic acid, or mixture thereof such that the intolerance reaction is suppressed or reduced.
Dependencies are inferred from the claim text.